Partisan Politics May Be To Blame For Hold Up In Walgreens-Rite Aid Deal

Partisan politics may be holding up the impending M&A deal between Walgreens Boots Alliance Inc WBA and Rite Aid Corporation RAD, Deutsche Bank said in a note earlier this week.

Walgreens may try to force a Federal Trade Commission decision on the deal within 30 days, analysts George Hill and Stephen Hagan said. Why does this matter? The traditionally five-member FTC board has three vacant seats.

The commissioner, a Democrat, may oppose the deal, and the chairperson, a Republican, is unlikely to vote against the deal, the analysts said.

Deutsche highlighted reports that suggested Walgreens could certify it has complied with the second request and force short-staffed FTC to make a decision. Media reports indicate the regulatory agency still has issues with the deal and with Fred's, Inc. FRED as a buyer, Deutsche Bank said.

See Also: A Positive View On Walgreens Doesn't Depend On Rite Aid Deal

Downside If Deal Fails

Deutsche Bank feels the downside to Walgreens is in the range of $73-$79 if the deal fails to close. This range, according to the firm, represents 14 to 15 times its calendar year 2017 earnings per share estimate of $5.24. Additionally, the firm said the range represents the current pharma services average to a one-turn premium, which the analysts feel is justifiable, given Walgreens' positive operating leverage and capital deployment flexibility, excluding a deal for Rite Aid.

If the deal falls through, Rite Aid shares could drop from $4.71 to $2.25, the firm said. The $2.25 stock price estimate is based on an EV/EBITDA multiple of eight times its calendar year 2017 estimates, with the multiple representing a "slight discount" from where Walgreens and CVS Health Corp CVS trade. This multiple, Deutsche Bank said, is fair for a subscale player in the competitive retail pharmacy space.

Deutsche Bank has a Buy rating on Walgreens with a $92 price target.

Image: Mike Mozart, Flickr

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorPoliticsLegalM&AAnalyst RatingsGeneralCVSDeutsche BankFTCGeorge HillStephen Hagan
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!